| Year |
Citation |
Score |
| 2024 |
Ye X, Wang T, Zhong L, Farrés J, Xia J, Zeng X, Cao D. Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer. Journal of Cancer. 15: 1657-1667. PMID 38370384 DOI: 10.7150/jca.91064 |
0.307 |
|
| 2019 |
He YC, He L, Khoshaba R, Lu FG, Cai C, Zhou FL, Liao DF, Cao D. Curcumin Nicotinate Selectively Induces Cancer Cell Apoptosis and Cycle Arrest through a P53-Mediated Mechanism. Molecules (Basel, Switzerland). 24. PMID 31752145 DOI: 10.3390/Molecules24224179 |
0.457 |
|
| 2019 |
Cao Z, Wu P, Su M, Ling H, Khoshaba R, Huang C, Gao H, Zhao Y, Chen J, Liao Q, Cao D, Jin J, Zhang X. Long non-coding RNA UASR1 promotes proliferation and migration of breast cancer cells through the AKT/mTOR pathway. Journal of Cancer. 10: 2025-2034. PMID 31205563 DOI: 10.7150/jca.29457 |
0.334 |
|
| 2019 |
Rao KA, Robinson K, Delfino K, Tiwari V, Zhu Y, Wang X, McClintock A, Bekker S, Westbrook J, Cao D, Cao Z. Analysis of AKR1B10 levels among various groups of breast cancer patients. Journal of Clinical Oncology. 37: e14548-e14548. DOI: 10.1200/Jco.2019.37.15_Suppl.E14548 |
0.387 |
|
| 2019 |
Wang X, Cao D. Abstract 502: Aldo-keto reductase 1B8 (AKR1B8) deficiency causes intestinal immune deficiency Cancer Research. 79: 502-502. DOI: 10.1158/1538-7445.Am2019-502 |
0.345 |
|
| 2018 |
Huang C, Cao Z, Ma J, Shen Y, Bu Y, Khoshaba R, Shi G, Huang D, Liao DF, Ji H, Jin J, Cao D. AKR1B10 Activates Diacylglycerol (DAG) Second Messenger in Breast Cancer Cells. Molecular Carcinogenesis. PMID 29846015 DOI: 10.1002/Mc.22844 |
0.647 |
|
| 2017 |
Cao Y, Lin M, Bu Y, Ling H, He Y, Huang C, Shen Y, Song B, Cao D. p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration. International Journal of Oncology. PMID 28339031 DOI: 10.3892/Ijo.2017.3918 |
0.631 |
|
| 2017 |
Cao Y, Cao D, Ling H. The novel long non-coding RNA PANCR: A p53 activator and potential breast cancer biomarkers. Journal of Clinical Oncology. 35: e23016-e23016. DOI: 10.1200/Jco.2017.35.15_Suppl.E23016 |
0.466 |
|
| 2016 |
Bu Y, Cai G, Shen Y, Huang C, Zeng X, Cao Y, Cai C, Wang Y, Huang D, Liao DF, Cao D. Targeting NF-κB RelA/p65 Phosphorylation Overcomes RITA Resistance. Cancer Letters. PMID 27721021 DOI: 10.1016/J.Canlet.2016.10.006 |
0.597 |
|
| 2016 |
Huang C, Verhulst S, Shen Y, Bu Y, Cao Y, He Y, Wang Y, Huang D, Cai C, Rao K, Liao DF, Jin J, Cao D. AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway. Oncotarget. PMID 27248472 DOI: 10.18632/Oncotarget.9672 |
0.629 |
|
| 2016 |
Zu X, Yan R, Pan J, Zhong L, Cao Y, Ma J, Cai C, Huang D, Liu J, Chung FL, Liao DF, Cao D. Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds. Molecular Carcinogenesis. PMID 26969882 DOI: 10.1002/Mc.22477 |
0.409 |
|
| 2016 |
He YC, Shen Y, Cao Y, Tang FQ, Tian DF, Huang CF, Tao H, Zhou FL, Zhang B, Song L, He L, Lin LM, Lu FG, Liao DF, Cao D. Overexpression of AKR1B10 in nasopharyngeal carcinoma as a potential biomarker. Cancer Biomarkers : Section a of Disease Markers. 16: 127-135. PMID 26835713 DOI: 10.3233/Cbm-150548 |
0.356 |
|
| 2016 |
Wang Z, Li S, Cao Y, Tian X, Zeng R, Liao DF, Cao D. Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer. Oxidative Medicine and Cellular Longevity. 2016: 9875298. PMID 26823956 DOI: 10.1155/2016/9875298 |
0.306 |
|
| 2016 |
Cao Z, Ma J, Chen X, Zhou B, Cai C, Huang D, Zhang X, Cao D. Uridine homeostatic disorder leads to DNA damage and tumorigenesis. Cancer Letters. PMID 26801745 DOI: 10.1016/J.Canlet.2016.01.007 |
0.302 |
|
| 2015 |
Bu Y, Li X, He Y, Huang C, Shen Y, Cao Y, Huang D, Cai C, Wang Y, Wang Z, Liao DF, Cao D. A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation. International Journal of Cancer. Journal International Du Cancer. PMID 26375985 DOI: 10.1002/Ijc.29852 |
0.62 |
|
| 2015 |
Pineda MJ, Lu Z, Cao D, Kim JJ. Influence of Cancer-Associated Endometrial Stromal Cells on Hormone-Driven Endometrial Tumor Growth. Hormones & Cancer. PMID 25976290 DOI: 10.1007/s12672-015-0223-4 |
0.314 |
|
| 2015 |
Shen Y, Ma J, Yan R, Ling H, Li X, Yang W, Gao J, Huang C, Bu Y, Cao Y, He Y, Wan L, Zu X, Liu J, Huang MC, ... ... Cao D, et al. Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1466-76. PMID 25538260 DOI: 10.1158/1078-0432.Ccr-14-2072 |
0.573 |
|
| 2015 |
Huang C, Bu Y, Cao D. Abstract 1142: COP1 functions as a sensor of cellular lipids and regulator of lipogenesis in human cancer cells Cancer Research. 75: 1142-1142. DOI: 10.1158/1538-7445.Am2015-1142 |
0.397 |
|
| 2014 |
He YC, Zhou FL, Shen Y, Liao DF, Cao D. Apoptotic death of cancer stem cells for cancer therapy. International Journal of Molecular Sciences. 15: 8335-51. PMID 24823879 DOI: 10.3390/ijms15058335 |
0.308 |
|
| 2014 |
Cao Z, Zhou B, Chen X, Huang D, Zhang X, Wang Z, Huang H, Wang Y, Cao D. Statil suppresses cancer cell growth and proliferation by the inhibition of tumor marker AKR1B10. Anti-Cancer Drugs. 25: 930-7. PMID 24800887 DOI: 10.1097/Cad.0000000000000121 |
0.444 |
|
| 2014 |
Shen Y, Ma J, Yan R, Ling H, Li X, Yang W, Gao J, Bu Y, Alsalman A, Huang C, Cao Y, Zhou S, Wan L, He Y, Wang Z, ... ... Cao D, et al. Abstract 5348: Impaired self-renewal and colitis susceptibility of colonic mucosa in mice lacking AKR1B8 Cancer Research. 74: 5348-5348. DOI: 10.1158/1538-7445.Am2014-5348 |
0.387 |
|
| 2013 |
Luo D, Bu Y, Ma J, Rajput S, He Y, Cai G, Liao DF, Cao D. Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes. The Journal of Biological Chemistry. 288: 36733-40. PMID 24217247 DOI: 10.1074/Jbc.M113.514877 |
0.579 |
|
| 2013 |
Chen Z, Liu F, Zhang N, Cao D, Liu M, Tan Y, Jiang Y. p38β, A novel regulatory target of Pokemon in hepatic cells. International Journal of Molecular Sciences. 14: 13511-24. PMID 23807508 DOI: 10.3390/ijms140713511 |
0.325 |
|
| 2013 |
Cao D, Liao DF. Author's reply to: AKR1B10 and its emerging role in tumor carcinogenesis and as a cancer biomarker. International Journal of Cancer. Journal International Du Cancer. 132: 496-7. PMID 22729652 DOI: 10.1002/Ijc.27684 |
0.354 |
|
| 2012 |
Lin J, Jin X, Bu Y, Cao D, Zhang N, Li S, Sun Q, Tan C, Gao C, Jiang Y. Efficient synthesis of RITA and its analogues: derivation of analogues with improved antiproliferative activity via modulation of p53/miR-34a pathway. Organic & Biomolecular Chemistry. 10: 9734-46. PMID 23151607 DOI: 10.1039/C2Ob26627J |
0.581 |
|
| 2012 |
Ma J, Luo DX, Huang C, Shen Y, Bu Y, Markwell S, Gao J, Liu J, Zu X, Cao Z, Gao Z, Lu F, Liao DF, Cao D. AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker. International Journal of Cancer. Journal International Du Cancer. 131: E862-71. PMID 22539036 DOI: 10.1002/Ijc.27618 |
0.624 |
|
| 2012 |
Liu Z, Yan R, Al-Salman A, Shen Y, Bu Y, Ma J, Luo DX, Huang C, Jiang Y, Wilber A, Mo YY, Huang MC, Zhao Y, Cao D. Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. The Biochemical Journal. 442: 273-82. PMID 22329800 DOI: 10.1042/Bj20111322 |
0.585 |
|
| 2012 |
Bu Y, Cao D. The origin of cancer stem cells. Frontiers in Bioscience (Scholar Edition). 4: 819-30. PMID 22202093 |
0.576 |
|
| 2012 |
Zu X, Zhang Q, Cao R, Liu J, Zhong J, Wen G, Cao D. Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update. Cell and Tissue Research. 347: 73-84. PMID 21845401 DOI: 10.1007/S00441-011-1225-3 |
0.396 |
|
| 2012 |
Ma J, Cao D. Abstract LB-156: The role of AKR1B10 in early tumorigenesis depends on AMP-activated protein Kinase-α checkpoint Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-156 |
0.487 |
|
| 2011 |
Zhong L, Shen H, Huang C, Jing H, Cao D. AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group. Toxicology and Applied Pharmacology. 255: 40-7. PMID 21640744 DOI: 10.1016/J.Taap.2011.05.014 |
0.311 |
|
| 2011 |
Luo DX, Peng XH, Xiong Y, Liao DF, Cao D, Li L. Dual role of insulin-like growth factor-1 in acetyl-CoA carboxylase-alpha activity in human colon cancer cells HCT-8: downregulating its expression and phosphorylation. Molecular and Cellular Biochemistry. 357: 255-62. PMID 21638027 DOI: 10.1007/S11010-011-0896-0 |
0.425 |
|
| 2011 |
Luo DX, Huang MC, Ma J, Gao Z, Liao DF, Cao D. Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway. The Biochemical Journal. 438: 71-80. PMID 21585341 DOI: 10.1042/Bj20110111 |
0.382 |
|
| 2011 |
Zu X, Ma J, Liu H, Liu F, Tan C, Yu L, Wang J, Xie Z, Cao D, Jiang Y. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Research : Bcr. 13: R26. PMID 21392388 DOI: 10.1186/Bcr2843 |
0.457 |
|
| 2011 |
Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, Wakabayashi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, ... ... Cao D, et al. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Research and Treatment. 130: 387-98. PMID 21188630 DOI: 10.1007/S10549-010-1300-6 |
0.47 |
|
| 2011 |
Liu W, Furuta E, Shindo K, Watabe M, Xing F, Pandey PR, Okuda H, Pai SK, Murphy LL, Cao D, Mo YY, Kobayashi A, Iiizumi M, Fukuda K, Xia B, et al. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway. Breast Cancer Research and Treatment. 128: 57-68. PMID 20665104 DOI: 10.1007/S10549-010-1076-8 |
0.466 |
|
| 2011 |
Pandey PR, Okuda H, Misako W, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, Wakabayashi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, ... ... Cao D, et al. Abstract 979: Upregulation of lipogenic genes, SREBP-1, ACLY, ACC-1 and FAS, confer proliferation and survival advantages to cancer stem-like cells in ductal carcinoma in situ Cancer Research. 71: 979-979. DOI: 10.1158/1538-7445.Am2011-979 |
0.439 |
|
| 2010 |
Joshi A, Rajput S, Wang C, Ma J, Cao D. Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10. Biological Chemistry. 391: 1371-8. PMID 21087085 DOI: 10.1515/Bc.2010.144 |
0.533 |
|
| 2010 |
Wan L, Cao D, Zeng J, Ziemba A, Pizzorno G. Activation of Stat1, IRF-1, and NF-kappaB is required for the induction of uridine phosphorylase by tumor necrosis factor-alpha and interferon-gamma. Nucleosides, Nucleotides & Nucleic Acids. 29: 488-503. PMID 20544543 DOI: 10.1080/15257771003729682 |
0.367 |
|
| 2010 |
Wang C, Rajput S, Watabe K, Liao DF, Cao D. Acetyl-CoA carboxylase-a as a novel target for cancer therapy. Frontiers in Bioscience (Scholar Edition). 2: 515-26. PMID 20036965 DOI: 10.2741/S82 |
0.378 |
|
| 2010 |
Joshi A, Cao D. TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect. Frontiers in Bioscience (Landmark Edition). 15: 180-94. PMID 20036814 DOI: 10.2741/3614 |
0.499 |
|
| 2009 |
Wang C, Yan R, Luo D, Watabe K, Liao DF, Cao D. Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. The Journal of Biological Chemistry. 284: 26742-8. PMID 19643728 DOI: 10.1074/Jbc.M109.022897 |
0.4 |
|
| 2009 |
Zhong L, Liu Z, Yan R, Johnson S, Zhao Y, Fang X, Cao D. Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels. Biochemical and Biophysical Research Communications. 387: 245-50. PMID 19563777 DOI: 10.1016/J.Bbrc.2009.06.123 |
0.329 |
|
| 2009 |
Liu J, Wen G, Cao D. Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives. Recent Patents On Anti-Cancer Drug Discovery. 4: 246-53. PMID 19522700 DOI: 10.2174/157489209789206931 |
0.403 |
|
| 2009 |
Wang C, Xu C, Sun M, Luo D, Liao DF, Cao D. Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis. Biochemical and Biophysical Research Communications. 385: 302-6. PMID 19450551 DOI: 10.1016/J.Bbrc.2009.05.045 |
0.425 |
|
| 2009 |
Liu Z, Zhong L, Krishack PA, Robbins S, Cao JX, Zhao Y, Chung S, Cao D. Structure and promoter characterization of aldo-keto reductase family 1 B10 gene. Gene. 437: 39-44. PMID 19236911 DOI: 10.1016/J.Gene.2009.02.007 |
0.352 |
|
| 2008 |
Ma J, Yan R, Zu X, Cheng JM, Rao K, Liao DF, Cao D. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. The Journal of Biological Chemistry. 283: 3418-23. PMID 18056116 DOI: 10.1074/Jbc.M707650200 |
0.429 |
|
| 2007 |
Yan R, Zu X, Ma J, Liu Z, Adeyanju M, Cao D. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention. International Journal of Cancer. 121: 2301-6. PMID 17597105 DOI: 10.1002/Ijc.22933 |
0.44 |
|
| 2007 |
Zu X, Yan R, Robbins S, Krishack PA, Liao DF, Cao D. Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression. Toxicological Sciences : An Official Journal of the Society of Toxicology. 97: 562-8. PMID 17329238 DOI: 10.1093/Toxsci/Kfm033 |
0.349 |
|
| 2006 |
Jin J, Krishack PA, Cao D. Role of aldo-keto reductases in development of prostate and breast cancer. Frontiers in Bioscience : a Journal and Virtual Library. 11: 2767-73. PMID 16720349 DOI: 10.2741/2006 |
0.381 |
|
| 2006 |
Yan R, Wan L, Pizzorno G, Cao D. Uridine phosphorylase in breast cancer: a new prognostic factor? Frontiers in Bioscience : a Journal and Virtual Library. 11: 2759-66. PMID 16720348 DOI: 10.2741/2005 |
0.427 |
|
| 2006 |
Wan L, Cao D, Zeng J, Yan R, Pizzorno G. Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells. Molecular Pharmacology. 69: 1389-95. PMID 16397116 DOI: 10.1124/Mol.105.018515 |
0.348 |
|
| 2002 |
Cao D, Russell RL, Zhang D, Leffert JJ, Pizzorno G. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines. Cancer Research. 62: 2313-7. PMID 11956089 |
0.369 |
|
| Show low-probability matches. |